Targeted Protein Degradation Platform: Audience

Nurix Therapeutics specializes in developing innovative medicines using targeted protein degradation to treat cancer and autoimmune diseases. Their approach combines degraders and Degrader-Antibody Conjugates (DACs) to enhance treatment precision and safety.